Doxorubicin toxicity in the Iron Age Friedrich C. Luft Clinical Implications 14 June 2006 Pages: 529 - 531
Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain Burkhard BecherIngo BechmannMelanie Greter Review 14 June 2006 Pages: 532 - 543
The endoproteolytic maturation of progastrin and procholecystokinin Jens F. Rehfeld Review 06 May 2006 Pages: 544 - 550
IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice Gianfranca CornaBruno GalyGaetano Cairo Original Article 13 June 2006 Pages: 551 - 560
The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability C. M. BrownT. J. ReaC. F. Sing Original Article 17 May 2006 Pages: 561 - 572
Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model Ming DuKim M. KeelingDavid M. Bedwell Original Article 16 March 2006 Pages: 573 - 582
Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers–Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (β4GalT-7) Daniela G. SeidlerMuhammad Faiyaz-Ul-HaqueMartin Götte Original Article 01 April 2006 Pages: 583 - 594
Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma Ya-Hui ChuangJau-Ling SuenBor-Luen Chiang Original Article 25 March 2006 Pages: 595 - 603
Molecular dissection reveals decreased activity and not dominant negative effect in human OTX2 mutants Gilles ChatelainNicolas FossatThomas Lamonerie Original Article 11 April 2006 Pages: 604 - 615
Association of a polymorphism in the betacellulin gene with type 1 diabetes mellitus in two populations Kristi D. SilverVictoria L. MagnusonBraxton D. Mitchell Original Article 09 May 2006 Pages: 616 - 623
